Palatin Technologies price to free cash flow PTN

Market value divided by free cash flow over the last twelve months, since 2017.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 5.6×; Feb 2023
9-year median: 5.3×
9-year range: 2.2× to 121×
Peer median: 11.0×

Palatin Technologies' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Feb 2023, at 5.6×.

On the days it had one over the last 9 years, its median was 5.3×, from 2.2× in Oct 2020 to 121× in Sep 2018.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	5.6×	5.6×	7.8×
2022	4.3×	4.0×	7.4×
2021	n/m a value too high to mean anything
2020	2.2×	2.2×	4.6×
2019	4.8×	4.5×	4.9×
2018	112×	6.4×	121×
2017	7.9×	4.4×	12.1×

Against its peers

Companies in Drug Manufacturers - General nearest Palatin Technologies' size, closest first, today.

Company	Price to free cash flow
PTNPalatin Technologies	n/m
ATNMActinium Pharmaceuticals	n/m
SPROSpero Therapeutics	n/m
LFVNLifevantage	11.0×
Peer median	11.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Palatin Technologies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.